Daniel Gamsu

The Discure System is designed to treat and reverse degenerative disc disease (DDD), healing the discs, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery. The company received FDA Breakthrough Device Designation, and an award for “Best New Technology in Spine Care in 2021” at the North American Spine Society (NASS) annual meeting, by a panel of KOL spinal surgeons and neurosurgeons. Investors include Rainbow Medical, Johnson & Johnson and multiple venture arms of US-based hospital networks.

STFix is developing a minimally invasive, rotator cuff repair implant for improved repair, quicker rehabilitation and reduced retear rate.

Liposphere is a biomedical start-up company spun out from the Weizmann Institute of Science (Israel) in 2019. The Company develops highly lubricious, water-based, biocompatible nanomaterials for conditions of the human body, where ultralow friction is of utmost importance. The team has spent over 10 years on basic academic research and development of the compound at the Weizmann Institute before spinning out the technology. LipOsphere’s technological advantage, based on the discovery of the Hydration Lubrication Mechanism, is worldwide IP protected.

The Discure System is designed to treat and reverse degenerative disc disease (DDD), healing the discs, reducing pain, and restoring function to patients, via a minimally invasive, implantable bioelectronic approach. Unlike existing treatments, that are symptom-focused, the Discure System is a disease-modifying solution, designed to reduce the use of opioids and the need for invasive back surgery. The company received FDA Breakthrough Device Designation, and an award for “Best New Technology in Spine Care in 2021” at the North American Spine Society (NASS) annual meeting, by a panel of KOL spinal surgeons and neurosurgeons. Investors include Rainbow Medical, Johnson & Johnson and multiple venture arms of US-based hospital networks.

STFix is developing a minimally invasive, rotator cuff repair implant for improved repair, quicker rehabilitation and reduced retear rate.

Liposphere is a biomedical start-up company spun out from the Weizmann Institute of Science (Israel) in 2019. The Company develops highly lubricious, water-based, biocompatible nanomaterials for conditions of the human body, where ultralow friction is of utmost importance. The team has spent over 10 years on basic academic research and development of the compound at the Weizmann Institute before spinning out the technology. LipOsphere’s technological advantage, based on the discovery of the Hydration Lubrication Mechanism, is worldwide IP protected.